Day: May 20, 2024

Aveanna to Participate at the UBS Healthcare Services Cape Cod Summit and Jefferies Global Healthcare Conference

ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the UBS Healthcare Services Cape Cod Summit in Chatham, MA on Tuesday, June 4, 2024, and the Jefferies Global Healthcare Conference in New York on Wednesday, June 5, 2024. Management will host 1×1 investor meetings at the UBS Healthcare Services Summit on June 4, 2024. For the Jefferies Global Healthcare Conference on June 5, 2024, management will host 1×1 investor meetings as well as a fireside chat at 3:30pm Eastern Time. Interested investors and other parties may also listen to a simultaneous webcast of the fireside chat by logging onto the Investor Relations section of the Company’s website at https://ir.aveanna.com/. The online replay will be available shortly after...

Continue reading

Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024

SEATTLE, May 20, 2024 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced the Company will present information pertaining to the Company’s sponsored studies of its assets at the Society of Nuclear Medicine & Molecular Imaging (“SNMMI”) Annual Meeting 2024, which is being held in Toronto, Canada, from June 8-11, 2024. The Company notes that results based on investigator-initiated use of its assets are also being presented. “We are greatly encouraged by the progress of our clinical and preclinical programs,” said Thijs Spoor, CEO of Perspective. “The upcoming presentations at the SNMMI meeting will showcase our activities with VMT-α-NET...

Continue reading

Mesa Air Group Reports First Quarter Fiscal 2024 Results

PHOENIX, May 20, 2024 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today reported first quarter fiscal 2024 financial and operating results. First Quarter Fiscal 2024 Update: Total operating revenues of $118.8 million Pre-tax loss of $57.0 million, net loss of $57.9 million or $(1.41) per diluted share Adjusted net loss1 of $21.8 million2 or $(0.53) per diluted share Adjusted EBITDAR1 of $6.3 million Block hours of 46,658, an approximate 5% increase over fourth quarter fiscal 2023 Paid down $39.2 million of debt during quarter with surplus CRJ asset sale proceeds Developments Subsequent to Quarter End: As announced in January 2024, United Airlines agreed to significantly higher block-hour rate on E-175 flying As a result of the reduction in cargo demand, Mesa and DHL mutually agreed to wind...

Continue reading

Nicole Robinson Appointed President of DataPath Inc.

David McDonald will transition to the role of Vice Chairman of DataPath Board of Directors. Nicole Robinson Appointed President of DataPath Inc. Nicole Robinson PETAH TIKVA, Israel, May 20, 2024 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that Nicole Robinson has been appointed as President of DataPath. Ms. Robinson is an international satellite industry executive with a proven record in driving growth, managing global sales and operational teams, and deploying next-generation technology for the benefit of government and defense organizations, businesses and communities globally. She has served in key roles at Comtech Telecommunications, Ursa Space Systems, SES and General Dynamics. “We are delighted...

Continue reading

Scorpio Tankers Inc. Announces Agreement for a $223.6 Million Prepayment under its 2023 $1.0 Billion Credit Facility

MONACO, May 20, 2024 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE:STNG) (“Scorpio Tankers,” or the “Company”) announced today that it has received approval from majority lenders under its 2023 $1.0 Billion Credit Facility to make an unscheduled repayment on the term portion of this credit facility in June 2024 of $223.6 million. This prepayment is to be applied against the eight quarterly principal installments of the term loan falling due between the third quarter of 2024 and the second quarter of 2026. Given the lower debt service costs arising from this prepayment, the Company’s cash break even rates are expected to decrease by approximately $3,500 per day for the first year following this prepayment. This repayment will not impact the availability under the revolving portion of this credit facility,...

Continue reading

Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints

– In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 mg/kg Cohort at 3 Months – – DYNE-101 Showed Improvement in Myotonia, Muscle Strength, and Timed Function Tests and in DM1-ACTIVc and MDHI Patient Reported Outcomes – – In Phase 1/2 DELIVER Trial, DYNE-251 Showed 3.2% Mean Unadjusted (7.6% Mean Muscle Adjusted) Dystrophin Expression at 6 Months in 10 mg/kg Cohort Administered Monthly; 10 Times Higher Level of Dystrophin Than Reported for Weekly Administered Standard of Care1– – DYNE-251 Demonstrated Trends in Functional Improvement in NSAA, Time to Rise from Floor, 10-Meter Walk/Run Time, and Stride Velocity 95th Centile at 6 Months in 10 mg/kg Cohort – – Favorable Safety Profiles for DYNE-101 and DYNE-251 with...

Continue reading

ECARX Announces First Quarter 2024 Unaudited Financial Results

Exhibit 99.1 SHANGHAI, China, May 20, 2024 (GLOBE NEWSWIRE) — ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, today announced unaudited financial results for the quarter ended March 31, 2024. “The strong growth momentum that we picked up last year continued into the first quarter with revenues increasing 21% year-over-year,” commented ECARX Chairman and CEO Ziyu Shen. “The development of software-defined vehicles and their underpinning technologies will determine the winners in this next stage of the auto revolution. Continued product innovation and a strong ecosystem of partnerships are key to capitalizing on this opportunity. The multiple ground-breaking automotive intelligence solutions that we unveiled during the quarter, and the synergies being created by our growing number of...

Continue reading

Vivid Seats to Participate in William Blair’s 2024 Growth Stock Conference

CHICAGO, May 20, 2024 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today announced that Stan Chia, Chief Executive Officer, and Lawrence Fey, Chief Financial Officer, will be presenting at William Blair’s 2024 Growth Stock Conference on Wednesday, June 5, 2024 at 8:40 a.m. CT. A live webcast of the presentation will be accessible on the Vivid Seats Investor Relations website at https://investors.vividseats.com/ under “News & Events.” About Vivid SeatsFounded in 2001, Vivid Seats is a leading online ticket marketplace committed to becoming the ultimate partner for connecting fans to the live events, artists, and teams they love. Based...

Continue reading

Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale

New production process will be developed based on Pluri’s proprietary 3D cell expansion technology Human breast milk oligosaccharides are known to shape the gut microbiota and thus provide health benefits to adults Global elderly nutrition market is valued at $25.2 billion, estimated to reach $39.7 billion in less than 10 years HAIFA, Israel, May 20, 2024 (GLOBE NEWSWIRE) — Leading biotechnology company Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), which transforms cells into solutions that promote global wellbeing and sustainability, today announced a strategic collaboration with Wilk Technologies Ltd. (TASE: WILK) (“Wilk Technologies” or “Wilk”), a developer of authentic, cell-cultured human and animal milk components. By combining Pluri’s cutting-edge 3D cell-expansion technology with Wilk’s expertise...

Continue reading

Highest Performances Holdings Inc. (NASDAQ: HPH) to Announce Unaudited Financial Results For The First Half of The Fiscal Year 2024 and Host Conference Call on May 30, 2024

GUANGZHOU, China, May 20, 2024 (GLOBE NEWSWIRE) — Highest Performances Holdings Inc. (NASDAQ: HPH) (“HPH” or the “Company”), today announced that it will release its unaudited financial results for the first half of its fiscal year 2024 ended December 31, 2023 on May 30, 2024. Senior management of the Company will host a bilingual conference call in English and Chinese to discuss the Company’s unaudited financial results and business development for the first half of its fiscal year 2024 ended December 31, 2023. Details for the conference call are as follows: Date/Time: Thursday, May 30, 2024 at 9:00 PM U.S. Eastern Time   (Friday, May 31, 2024 at 9:00 AM Beijing/Hong Kong Time) Conference Title: Highest Performances Holdings Inc. Six Months Ended December 31, 2023 Earnings Call     Please pre-register online in advance...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.